Literature DB >> 10669100

Establishment and characterization of an Oklahoma isolate of Anaplasma marginale in cultured Ixodes scapularis cells.

E F Blouin1, A F Barbet, J Yi, K M Kocan, J T Saliki.   

Abstract

Anaplasma marginale is a tick-borne hemoparasite of cattle worldwide. The Virginia isolate of A. marginale was propagated previously in a cell line derived from embryos of the tick, Ixodes scapularis. The cultured Anaplasma (VA-tc) was passaged continuously for over 4 years and retained its infectivity for cattle and antigenic stability. We report herein the continuous in vitro cultivation of a second isolate of A. marginale derived from a naturally infected cow in Oklahoma (OK-tc). Blood from the infected cow was subinoculated into a splenectomized calf and blood collected at peak parasitemia was frozen, thawed and used as inoculum on confluent tick cell monolayers. Colonies of Anaplasma were apparent in low numbers at 9 days post exposure (PE) and infection in monolayers reached 100% by 4-5 weeks PE. Cultures were passaged by placing supernatant onto fresh tick cell monolayers at a dilution of 1:5 or 1:10. By the third passage development of the OK-tc was similar to that of the VA-tc and a 1:5 dilution resulted in 100% infection in 10-12 days. Inoculation of OK-tc into a splenectomized calf caused clinical anaplasmosis and Dermacentor ticks that fed on this calf transmitted the organism to a second susceptible calf. Major surface proteins (MSPs) 1-5 of the OK-tc were compared with homologous proteins present on VA-tc and the erythrocytic stage of the Oklahoma isolate. The MSPs 1, 2, 4, 5 were conserved on the OK-tc but there was evidence for structural variation in MSP3 between the cultured and erythrocytic stage of Anaplasma. MSP2 and MSP3 were the major proteins recognized by serum from infected cattle. Two-dimensional gels also identified positional differences between VA-tc and OK-tc in MSP2 and MSP3. The OK-tc may have potential to be used as antigen for development of an improved vaccine for anaplasmosis in the South Central United States.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669100     DOI: 10.1016/s0304-4017(99)00183-1

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  10 in total

1.  Infection of tick cells and bovine erythrocytes with one genotype of the intracellular ehrlichia Anaplasma marginale excludes infection with other genotypes.

Authors:  José de la Fuente; Jose C Garcia-Garcia; Edmour F Blouin; Jeremiah T Saliki; Katherine M Kocan
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

2.  Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle.

Authors:  A F Barbet; J Yi; A Lundgren; B R McEwen; E F Blouin; K M Kocan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Targeted mutagenesis in Anaplasma marginale to define virulence and vaccine development against bovine anaplasmosis.

Authors:  Paidashe Hove; Swetha Madesh; Arathy Nair; Deborah Jaworski; Huitao Liu; Jonathan Ferm; Michael D Kleinhenz; Margaret A Highland; Andrew K Curtis; Johann F Coetzee; Susan M Noh; Ying Wang; Dominica Genda; Roman R Ganta
Journal:  PLoS Pathog       Date:  2022-05-16       Impact factor: 7.464

Review 4.  Antigens and alternatives for control of Anaplasma marginale infection in cattle.

Authors:  Katherine M Kocan; José de la Fuente; Alberto A Guglielmone; Roy D Meléndez
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

5.  Glycosylation of Anaplasma marginale major surface protein 1a and its putative role in adhesion to tick cells.

Authors:  Jose C Garcia-Garcia; José de la Fuente; Gianna Bell-Eunice; Edmour F Blouin; Katherine M Kocan
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

Review 6.  Adaptations of the tick-borne pathogen, Anaplasma marginale, for survival in cattle and ticks.

Authors:  Katherine M Kocan; Jose De La Fuente; Edmour F Blouin; Jose Carlos Garcia-Garcia
Journal:  Exp Appl Acarol       Date:  2002       Impact factor: 2.132

7.  Development of a subcutaneous ear implant to deliver an anaplasmosis vaccine to dairy steers.

Authors:  Andrew K Curtis; Kathryn E Reif; Michael D Kleinhenz; Miriam S Martin; Brandt Skinner; Sean M Kelly; Douglas E Jones; Robert G Schaut; Emily J Reppert; Shawnee R Montgomery; Balaji Narasimhan; Tippawan Anantatat; Majid Jaberi-Douraki; Johann F Coetzee
Journal:  J Anim Sci       Date:  2020-06-01       Impact factor: 3.159

8.  Draft Genome Sequences of Anaplasma phagocytophilum, A. marginale, and A. ovis Isolates from Different Hosts.

Authors:  Sandra Diaz-Sanchez; Angélica Hernández-Jarguín; Isabel G Fernández de Mera; Pilar Alberdi; Erich Zweygarth; Christian Gortazar; José de la Fuente
Journal:  Genome Announc       Date:  2018-02-01

9.  Cultivation of Anaplasma ovis in the HL-60 human promyelocytic leukemia cell line.

Authors:  Ran Wei; Hong-Bo Liu; Frans Jongejan; Bao-Gui Jiang; Qiao-Cheng Chang; Xue Fu; Jia-Fu Jiang; Na Jia; Wu-Chun Cao
Journal:  Emerg Microbes Infect       Date:  2017-09-20       Impact factor: 7.163

10.  In vitro establishment and propagation of a Brazilian strain of Anaplasma marginale with appendage in IDE8 (Ixodes scapularis) cells.

Authors:  Camila V Bastos; Lygia M F Passos; Maria Mercês C Vasconcelos; Múcio F B Ribeiro
Journal:  Braz J Microbiol       Date:  2009-06-01       Impact factor: 2.476

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.